Apollomics (APLM) Cash & Equivalents (2022 - 2025)

Apollomics has reported Cash & Equivalents over the past 4 years, most recently at $3.3 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 66.21% to $3.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.3 million through Dec 2025, down 66.21% year-over-year, with the annual reading at $3.3 million for FY2025, 66.21% down from the prior year.
  • Cash & Equivalents was $3.3 million for Q4 2025 at Apollomics, down from $9.8 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $32.7 million in Q4 2022 and troughed at $3.3 million in Q4 2025.
  • The 4-year median for Cash & Equivalents is $20.9 million (2023), against an average of $19.4 million.
  • Biggest five-year swings in Cash & Equivalents: decreased 1.89% in 2023 and later tumbled 69.53% in 2024.
  • Tracing APLM's Cash & Equivalents over 4 years: stood at $32.7 million in 2022, then dropped by 1.89% to $32.1 million in 2023, then tumbled by 69.53% to $9.8 million in 2024, then tumbled by 66.21% to $3.3 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $3.3 million, $9.8 million, and $32.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.